Denosumab Subcutaneous and Skyrizi Injection
Determining the interaction of Denosumab Subcutaneous and Skyrizi Injection and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Concomitant use of immunosuppressive or myelosuppressive agents with denosumab may increase the risk of serious infections. Denosumab binds to and inhibits the receptor activator of nuclear factor kappa-B ligand (RANKL), which is expressed on activated T and B lymphocytes and in lymph nodes. Thus, denosumab alone may increase the risk of infections. In a clinical trial of over 7800 women with postmenopausal osteoporosis, the incidence of nonfatal serious infections was 3.3% in the placebo group and 4.0% in the denosumab group. Specifically, hospitalizations due to skin infections including erysipelas and cellulitis (
Professional:MONITOR: Concomitant use of immunosuppressive or myelosuppressive agents with denosumab may increase the risk of serious infections. Denosumab binds to and inhibits the receptor activator of nuclear factor kappa-B ligand (RANKL), which is expressed on activated T and B lymphocytes and in lymph nodes. Thus, denosumab alone may increase the risk of infections. In a clinical trial of over 7800 women with postmenopausal osteoporosis, the incidence of nonfatal serious infections was 3.3% in the placebo group and 4.0% in the denosumab group. Specifically, hospitalizations due to skin infections including erysipelas and cellulitis (
- "Product Information. Prolia (denosumab)." Amgen USA, Thousand Oaks, CA.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Skyrizi topical
- Denosumab Subcutaneous-Sleep Aid
- Denosumab Subcutaneous-Sleep Aid Tablets
- Denosumab Subcutaneous-Sleepinal
- Denosumab Subcutaneous-Slo-Niacin
- Denosumab Subcutaneous-Slow Fe
- Skyrizi Injection-Denovo
- Skyrizi Injection-Dent-O-Kain/20
- Skyrizi Injection-Denti-Care Denti-Freeze Topical Anesthetic
- Skyrizi Injection-DentiPatch
- Skyrizi Injection-Deoxycholic acid
- Skyrizi Injection-Deoxycholic acid Subcutaneous